The Patent Finder

The Methodist Hospital

37 patents currently held · Updated Nov 16, 2026
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

0
Ending by 2030
Oct 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Mar 17 to 24, 2027 · next Mar 17
  • 1 fee due May 14, 2027
    The maintenance fee for Method and apparatus for the fail-safe termination of in vivo drug delivery from an implantable drug delivery system (US 11,813,432) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Jun 10, 2027
    The maintenance fee for Method and Apparatus for Providing Transcranial Magnetic Stimulation (TMS) to a Patient (US 10,500,408) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
  • 1 fee due Aug 11, 2027
    The maintenance fee for Chemotherapeutic compositions and methods for treating human gliomas (US 10,555,936) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
  • 1 fee due Oct 23, 2027
    The maintenance fee for Systems and methods for computer-aided orthognathic surgical planning (US 11,963,832) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,555,936Chemotherapeutic compositions and methods for treating human gliomas
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,291,853Method and Apparatus for Providing Transcranial Magnetic Stimulation (TMS) to a Patient
In force
 · High confidence
In forceHigh confidence
US 10,500,408Method and Apparatus for Providing Transcranial Magnetic Stimulation (TMS) to a Patient
In force
 · Medium confidence
In forceMedium confidence
US 9,456,784Method and Apparatus for Providing Transcranial Magnetic Stimulation (TMS) to a Patient
In force
 · High confidence
In forceHigh confidence
US 10,130,713Cocrystalline DHEA Formulations
In force
 · High confidence
In forceHigh confidence
US D856,517Asymmetric Tissue Graft
In force
 · High confidence
In forceHigh confidence
US 10,722,129Imaging System for Intra-Operative and Post-Operative Blood Perfusion Monitoring
In force
 · High confidence
In forceHigh confidence
US 10,420,838Methods for Treating Cancer Using Inos-Inhibitory Compositions
In force
 · Medium confidence
In forceMedium confidence
US 11,357,850Methods for Treating Breast Cancer Using Inos-Inhibitory Compositions
In force
 · Medium confidence
In forceMedium confidence
US 10,413,209Method and apparatus for identifying the ureter during a minimally-invasive procedure
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
Also on record, not counted in the 37: 10 patents in force now held by others · 12 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

22 pending · 12 abandoned · 32 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited